Operating in Canada since 2009, Accord Healthcare is committed to providing high- quality, cost-effective medicines to Canadian patients. With a focus on Oncology, Accord Healthcare markets generic, specialty branded and biopharma products across numerous therapeutic categories. Our current portfolio consists of more then 180 products, spread across 60 molecules; many of which have leading market share positions in Canada. Accord Healthcare’s global pipeline and vertically integrated production network enable us to consistently grow our offering of new and necessary medicines for Canadians.